Ultragenyx Pharmaceutical For Profit
.jpg)
Theradaptive develops targeted therapeutics using its proprietary THX1 platform
Investors
Technology:
Pharmaceuticals
Industry:
Regenerative medicine
Headquarters:
United States
Estimated Revenue:
$50M to $100M
Register and Claim Ownership